Long-Term Follow-Up of Pediatric Patients with Dyskinetic Cerebral Palsy and Deep Brain Stimulation.


Journal

Movement disorders : official journal of the Movement Disorder Society
ISSN: 1531-8257
Titre abrégé: Mov Disord
Pays: United States
ID NLM: 8610688

Informations de publication

Date de publication:
09 2023
Historique:
revised: 16 05 2023
received: 24 02 2023
accepted: 05 06 2023
medline: 19 9 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

Deep brain stimulation (DBS) has been increasingly used in the management of dyskinetic cerebral palsy (DCP). Data on long-term effects and the safety profile are rare. We assessed the efficacy and safety of pallidal DBS in pediatric patients with DCP. The STIM-CP trial was a prospective, single-arm, multicenter study in which patients from the parental trial agreed to be followed-up for up to 36 months. Assessments included motor and non-motor domains. Of the 16 patients included initially, 14 (mean inclusion age 14 years) were assessed. There was a significant change in the (blinded) ratings of the total Dyskinesia Impairment Scale at 36 months. Twelve serious adverse events (possibly) related to treatment were documented. DBS significantly improved dyskinesia, but other outcome parameters did not change significantly. Investigations of larger homogeneous cohorts are needed to further ascertain the impact of DBS and guide treatment decisions in DCP. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Sections du résumé

BACKGROUND
Deep brain stimulation (DBS) has been increasingly used in the management of dyskinetic cerebral palsy (DCP). Data on long-term effects and the safety profile are rare.
OBJECTIVES
We assessed the efficacy and safety of pallidal DBS in pediatric patients with DCP.
METHODS
The STIM-CP trial was a prospective, single-arm, multicenter study in which patients from the parental trial agreed to be followed-up for up to 36 months. Assessments included motor and non-motor domains.
RESULTS
Of the 16 patients included initially, 14 (mean inclusion age 14 years) were assessed. There was a significant change in the (blinded) ratings of the total Dyskinesia Impairment Scale at 36 months. Twelve serious adverse events (possibly) related to treatment were documented.
CONCLUSION
DBS significantly improved dyskinesia, but other outcome parameters did not change significantly. Investigations of larger homogeneous cohorts are needed to further ascertain the impact of DBS and guide treatment decisions in DCP. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Identifiants

pubmed: 37358761
doi: 10.1002/mds.29516
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1736-1742

Informations de copyright

© 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Références

Lin JP, Lumsden DE, Gimeno H, Kaminska M. The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tretiary cohort study. J Neurol Neurosurg Psychiatr 2014;85:1239-1244.
Koy A, Lin JP, Sanger TD, Marks WA, Mink JW, Timmermann L. Advances in management of movement disorders in children. Lancet Neurol 2016;15(7):719-735.
Vidailhet M, Yelnik J, Lagrange C, et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol 2009;8(8):709-717.
Romito LM, Zorzi G, Marras CE, Franzini A, Nardocci N, Albanese A. Pallidal stimulation for acquired dystonia due to cerebral palsy: beyond 5 years. Eur J Neurol 2015;22(3):426-e432.
Koy A, Kühn AA, Huebl J, et al. Quality of life after deep brain stimulation of pediatric patients with dyskinetic cerebral palsy: a prospective, single-arm, multicenter study with a subsequent randomized double-blind crossover (STIM-CP). Mov Disord 2022;37(4):799-811.
Koy A. Effect of deep brain stimulation of the Globus pallidus internus on quality of life in young patients with dyskinetic cerebral palsy (STIMCP): a prospective single-arm multicenter trial with a double-blind cross-over at 12-months follow-up. J Clin Trials 2017;7(4):1-9.
Air EL, Ostrem JL, Sanger TD, Starr PA. Deep brain stimulation in children: experience and technical pearls. J Neurosurg Pediatr 2011;8(6):566-574.
Volkmann J, Wolters A, Kupsch A, et al. Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol 2012;11(12):1029-1038.
Bruggemann N, Kuhn A, Schneider SA, et al. Short- and long-term outcome of chronic pallidal neurostimulation in monogenic isolated dystonia. Neurology 2015;84(9):895-903.
Elia AE, Bagella CF, Ferre F, Zorzi G, Calandrella D, Romito LM. Deep brain stimulation for dystonia due to cerebral palsy: a review. Eur J Paediatr Neurol 2018;22(2):308-315.
Ruge D, Cif L, Limousin P, et al. Shaping reversibility? Long-term deep brain stimulation in dystonia: the relationship between effects on electrophysiology and clinical symptoms. Brain 2011;134(Pt 7):2106-2115.
Cif L, Ruge D, Gonzalez V, et al. The influence of deep brain stimulation intensity and duration on symptoms evolution in an OFF stimulation dystonia study. Brain Stimul 2013;6(4):500-505.
Lumsden DE, Kaminska M, Gimeno H, et al. Proportion of life lived with dystonia inversely correlates with response to pallidal deep brain stimulation in both primary and secondary childhood dystonia. Dev Med Child Neurol 2013;55(6):567-574.
Isaias IU, Volkmann J, Kupsch A, et al. Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration. J Neurol 2011;258(8):1469-1476.
Ismail FY, Fatemi A, Johnston MV. Cerebral plasticity: windows of opportunity in the developing brain. Eur J Paediatr Neurol 2017;21(1):23-48.
Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28(7):863-873.
Monbaliu E, Himmelmann K, Lin JP, et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol 2017;16(9):741-749.
Koy A, Hellmich M, Pauls KA, Marks W, Lin JP, Fricke O, Timmermann L. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord 2013;28(5):647-654.
Pearson TS, Pons R, Ghaoui R, Sue CM. Genetic mimics of cerebral palsy. Mov Disord 2019;34(5):625-636.
Zech M, Jech R, Boesch S, et al. Monogenic variants in dystonia: an exome-wide sequencing study. Lancet Neurol 2020;19(11):908-918.
Palisano RJ, Almarsi N, Chiarello LA, Orlin MN, Bagley A, Maggs J. Family needs of parents of children and youth with cerebral palsy. Child Care Health Dev 2010;36(1):85-92.
Lumsden DE, Gimeno H, Tustin K, Kaminska M, Lin JP. Interventional studies in childhood dystonia do not address the concerns of children and their carers. Eur J Paediatr Neurol 2015;19(3):327-336.
Kaminska M, Perides S, Lumsden DE, et al. Complications of deep brain stimulation (DBS) for dystonia in children-the challenges and 10 year experience in a large paediatric cohort. Eur J Paediatr Neurol 2017;21(1):168-175.
Koy A, Bockhorn N, Kühn AA, et al. Adverse events associated with deep brain stimulation in patients with childhood-onset dystonia. Brain Stimul 2019;12(5):1111-1120.

Auteurs

Anne Koy (A)

Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Andrea A Kühn (AA)

Department of Neurology, Charité University Medicine Berlin, Berlin, Germany.

Petra Schiller (P)

Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Julius Huebl (J)

Department of Neurology, Charité University Medicine Berlin, Berlin, Germany.
Department of Neurology, Munich Municipal Hospital Bogenhausen, Munich, Germany.

Gerd-Helge Schneider (GH)

Department of Neurosurgery, Charité University Medicine, Berlin, Germany.

Matthias Eckenweiler (M)

Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Cornelia Rensing-Zimmermann (C)

Department of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Volker Arnd Coenen (VA)

Department of Stereotactic and Functional Neurosurgery, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Center for Deep Brain Stimulation, University Medical Center, Freiburg, Germany.

Joachim K Krauss (JK)

Department of Neurosurgery, Hannover Medical School, Hannover, Germany.

Assel Saryyeva (A)

Department of Neurosurgery, Hannover Medical School, Hannover, Germany.

Hans Hartmann (H)

Clinic for Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Germany.

Delia Lorenz (D)

Department of Pediatrics, University Children's Hospital, Wuerzburg, Germany.

Jens Volkmann (J)

Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Cordula Matthies (C)

Department of Stereotactic and Functional Neurosurgery, University Hospital Würzburg, Würzburg, Germany.

Alfons Schnitzler (A)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Jan Vesper (J)

Department of Functional Neurosurgery and Stereotaxy, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Alireza Gharabaghi (A)

Institute for Neuromodulation and Neurotechnology, Department of Neurosurgery and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.

Daniel Weiss (D)

Department of Neurology, Medical Faculty, University of Tübingen, Tübingen, Germany.

Andrea Bevot (A)

Department of Pediatric Neurology and Developmental Medicine, University Children's Hospital Tübingen, Tübingen, Germany.

Warren Marks (W)

Department of Neurology, Cook Children's Medical Center, Fort Worth, Texas, USA.
Department of Pediatrics, University of North Texas Health Sciences Center, Fort Worth, Texas, USA.

Angela Howser (A)

Department of Pediatrics, University of North Texas Health Sciences Center, Fort Worth, Texas, USA.

Elegast Monbaliu (E)

Department of Rehabilitation Sciences, KU Leuven Campus Bruges, Brugge, Belgium.

Joerg Mueller (J)

Department of Neurology, Vivantes Klinikum Spandau, Berlin, Germany.

Reinhild Prinz-Langenohl (R)

Clinical Trials Center Cologne, Cologne, Germany.

Veerle Visser-Vandewalle (V)

Department of Stereotactic and Functional Neurosurgery, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Lars Timmermann (L)

Department of Neurology, University Hospital of Marburg, Marburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH